Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (291-300 of 358) with videos related to

Pageof 36
Sort By:
Journal of Korean Medical Science|November 9, 2011
Dura mater graft-associated Creutzfeldt-Jakob disease: the first case in KoreaHye Lim Kim, Ju Young Do, Han Jeong Cho, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 25, 2019
The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluidLaura Kranaster, Carolin Hoyer, Sonani Mindt, et al.
Nature Communications|February 1, 2020
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementiaFranc Llorens, Peter Hermann, Anna Villar-Piqué, et al.
Journal of Neurology|May 16, 2009
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathiesAnna Ladogana, Pascual Sanchez-Juan, Eva Mitrová, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2019
RNA editing alterations define manifestation of prion diseasesEirini Kanata, Franc Llorens, Dimitra Dafou, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersZampeta-Sofia Alexopoulou, Qingyue Li, Stefanie Köhler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2019
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug developmentSonia M Vallabh, Chloe K Nobuhara, Franc Llorens, et al.
The Lancet. Neurology|February 20, 2021
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob diseasePeter Hermann, Brian Appleby, Jean-Philippe Brandel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 21, 2025
Correction: Neural autoantibodies in psychiatric disorders are associated with antibodies against viral pathogens: a retrospective study of 619 patientsNiels Hansen, Vincent Buschatzky, Anne Katharina Bastin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2016
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseasesFranc Llorens, Niels Kruse, Matthias Schmitz, et al.
Pageof 36

Showing results (291-300 of 358) with videos related to

Sort By:
Pageof 36
Journal of Korean Medical Science|November 9, 2011
Dura mater graft-associated Creutzfeldt-Jakob disease: the first case in KoreaHye Lim Kim, Ju Young Do, Han Jeong Cho, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 25, 2019
The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluidLaura Kranaster, Carolin Hoyer, Sonani Mindt, et al.
Nature Communications|February 1, 2020
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementiaFranc Llorens, Peter Hermann, Anna Villar-Piqué, et al.
Journal of Neurology|May 16, 2009
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathiesAnna Ladogana, Pascual Sanchez-Juan, Eva Mitrová, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2019
RNA editing alterations define manifestation of prion diseasesEirini Kanata, Franc Llorens, Dimitra Dafou, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersZampeta-Sofia Alexopoulou, Qingyue Li, Stefanie Köhler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2019
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug developmentSonia M Vallabh, Chloe K Nobuhara, Franc Llorens, et al.
The Lancet. Neurology|February 20, 2021
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob diseasePeter Hermann, Brian Appleby, Jean-Philippe Brandel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 21, 2025
Correction: Neural autoantibodies in psychiatric disorders are associated with antibodies against viral pathogens: a retrospective study of 619 patientsNiels Hansen, Vincent Buschatzky, Anne Katharina Bastin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2016
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseasesFranc Llorens, Niels Kruse, Matthias Schmitz, et al.
Pageof 36